More articles from Commentary

You have access
Validation: Why, What, When, How Much
Daniel H. GOLD

PDA Journal of Pharmaceutical Science and Technology January 1996, 50 (1) 55-60;
You have access
Harmonization, Regulation, and Trade: Where Do We Go from Here?
LINDA R. HORTON

PDA Journal of Pharmaceutical Science and Technology January 1996, 50 (1) 61-65;
You have access
Drugs, Devices and Delivery Considerations in Parenteral Pharmaceutical Care, or, What Are They Doing with Our Drugs? [Panel Discussion Presentation]
Loyd V. Allen

PDA Journal of Pharmaceutical Science and Technology November 1995, 49 (6) 306-308;
You have access
Compatibility Issues in Parenteral Administration [Panel Discussion Presentation]
Lawrence A. Trissel

PDA Journal of Pharmaceutical Science and Technology November 1995, 49 (6) 309-313;
You have access
Regulatory Aspects of Isolation/Barrier Technology
James C. Lyda

PDA Journal of Pharmaceutical Science and Technology November 1995, 49 (6) 300-304;
You have access
Compatibility of SVPs and LVPs with Drug Delivery Systems [Panel Discussion Introduction]
Dana Morton Guazzo

PDA Journal of Pharmaceutical Science and Technology November 1995, 49 (6) 305;
You have access
Opportunities and Obstacles in the Implementation of Barrier Technology
James Agalloco

PDA Journal of Pharmaceutical Science and Technology September 1995, 49 (5) 244-248;
You have access
Validation, Risk-Benefit Analysis
Robert G. Kieffer

PDA Journal of Pharmaceutical Science and Technology September 1995, 49 (5) 249-252;
You have access
Sterility Test Incubation Issue
James D. Wilson and Mark Varney

PDA Journal of Pharmaceutical Science and Technology July 1995, 49 (4) 157-159;
You have access
Validation: An Unconventional Review and Reinvention
James Agalloco

PDA Journal of Pharmaceutical Science and Technology July 1995, 49 (4) 175-179;

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.